Fortrea Holdings (FTRE) Total Liabilities (2022 - 2026)
Fortrea Holdings (FTRE) reported Total Liabilities of $2.2 billion for Q1 2026, down 4.63% on a YoY basis from $2.3 billion in Q1 2025, and little changed quarter-over-quarter from $2.2 billion in Q4 2025.
Fortrea Holdings (FTRE) Total Liabilities (2022 - 2026) Analysis & Trends
Fortrea Holdings has reported Total Liabilities for 5 years, with the latest figure at $2.2 billion in Q1 2026.
- For the quarter ending Q1 2026, Total Liabilities fell 4.63% year-over-year to $2.2 billion; the trailing twelve-month figure through Mar 2026 stood at $2.2 billion (down 4.63% YoY), and the FY2025 full-year result was $2.2 billion, down 2.91% from the prior year.
- Total Liabilities for Q1 2026 stood at $2.2 billion, roughly flat from $2.2 billion in the prior quarter.
- The five-year high for Total Liabilities was $2.6 billion in Q1 2024, with the low at -$3.4 billion in Q1 2023.
- Historically, Total Liabilities has averaged $1.5 billion across 5 years, with a median of $2.2 billion in 2025.
- Annual changes were most pronounced in 2023 — Total Liabilities surged 178.98% — and 2024, when it retreated 19.22%.
- Fortrea Holdings' Total Liabilities stood at $945.3 million in 2022, then jumped by 177.0% to $2.6 billion in 2023, then fell by 15.34% to $2.2 billion in 2024, then fell by 2.91% to $2.2 billion in 2025, then advanced by 0.25% to $2.2 billion in 2026.
- The last three Total Liabilities figures came in at $2.2 billion (Q1 2026), $2.2 billion (Q4 2025), and $2.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 1.74 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.48 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 731.60 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 10.44 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 19.51 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 943,068.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 7.12 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 137.56 Mn |
| 10 | Fortrea Holdings | 1.43 Bn | 1.28 Bn | 123.60 Mn | 2.16 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.16 Bn |
| Dec 31, 2025 | 2.15 Bn |
| Sep 30, 2025 | 2.16 Bn |
| Jun 30, 2025 | 2.25 Bn |
| Mar 31, 2025 | 2.26 Bn |
| Dec 31, 2024 | 2.22 Bn |
| Sep 30, 2024 | 2.15 Bn |
| Jun 30, 2024 | 2.10 Bn |
| Mar 31, 2024 | 2.65 Bn |
| Dec 31, 2023 | 2.62 Bn |
| Sep 30, 2023 | 2.62 Bn |
| Jun 30, 2023 | 2.61 Bn |
| Mar 31, 2023 | -3.40 Bn |
| Dec 31, 2022 | 945.30 Mn |
| Jun 30, 2022 | -3.30 Bn |